Cargando…
Identification of Meflin as a Potential Marker for Mesenchymal Stromal Cells
Bone marrow-derived mesenchymal stromal cells (BM-MSCs) in culture are derived from BM stromal cells or skeletal stem cells. Whereas MSCs have been exploited in clinical medicine, the identification of MSC-specific markers has been limited. Here, we report that a cell surface and secreted protein, M...
Autores principales: | Maeda, Keiko, Enomoto, Atsushi, Hara, Akitoshi, Asai, Naoya, Kobayashi, Takeshi, Horinouchi, Asuka, Maruyama, Shoichi, Ishikawa, Yuichi, Nishiyama, Takahiro, Kiyoi, Hitoshi, Kato, Takuya, Ando, Kenju, Weng, Liang, Mii, Shinji, Asai, Masato, Mizutani, Yasuyuki, Watanabe, Osamu, Hirooka, Yoshiki, Goto, Hidemi, Takahashi, Masahide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770287/ https://www.ncbi.nlm.nih.gov/pubmed/26924503 http://dx.doi.org/10.1038/srep22288 |
Ejemplares similares
-
Meflin defines mesenchymal stem cells and/or their early progenitors with multilineage differentiation capacity
por: Hara, Akitoshi, et al.
Publicado: (2021) -
Roles of the Mesenchymal Stromal/Stem Cell Marker Meflin/Islr in Cancer Fibrosis
por: Takahashi, Masahide, et al.
Publicado: (2021) -
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade
por: Miyai, Yuki, et al.
Publicado: (2022) -
Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer
por: Horio, Maiko, et al.
Publicado: (2012) -
Suppression of skin tumorigenesis in CD109-deficient mice
por: Sunagawa, Masaki, et al.
Publicado: (2016)